Enteris BioPharma
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
83 Fulton St, Boonton, New Jersey, 07005...Phone Number
(973) 453-3530Website
www.enterisbiopharma.comRevenue
$6.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Enteris BioPharma
MOD3 Pharma specializes in the development of Orally Inhaled and Nasal Drug Products (OINDP), providing clinic-ready solutions through their extensive CMC experience. They offer a range of services including formulation development, cGMP manufacturing, and clinical supply chain management, aimed at efficiently bringing projects to life. Their intended clients include pharmaceutical companies and organizations involved in drug development, particularly those focusing on investigational drugs. With a commitment to quality and innovation, MOD3 Pharma positions itself as a catalyst for clients looking to navigate the complexities of drug development.Explore more
Enteris BioPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Enteris BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Enteris BioPharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Enteris BioPharma recently announced quarterly report
Check out if Enteris BioPharma is spiking on competitors!
Funding: Get notified immidiatlly once Enteris BioPharma has new funding data
Click to see if Enteris BioPharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Enteris BioPharma launches new products
Enteris BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Enteris BioPharma
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Enteris BioPharma
Compare insights from companies similar to Enteris BioPharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Enteris BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Enteris BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Enteris BioPharma.
Enteris BioPharma Tech Stack
A closer look at the technologies used by Enteris BioPharma
See more technologies
Most Recent Scoops
Award
Award
Facilities Relocation / Expansion
Facilities Relocation/Expansion
Project
Product Development, Business Development
New Hire
Executive Move
Enteris BioPharma News & Media
Enteris BioPharma Publishes White Paper Examining Factors to Consider While Evaluating Oral Administration of Peptides
Physicochemical properties of peptides can provide key insights to potential success of oral delivery BOONTON, N.J., Sept. 12, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a...Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsourcing Formulation Development & Manufacturing
Article describes Enteris' strengths and scalability in working with highly potent active pharmaceutical ingredients BOONTON, N.J., August 3, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery...Enteris BioPharma Announces Acceptance of Abstract for Oral Presentation at ASRM 2022 Scientific Congress & Expo
BOONTON, N.J., July 14, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today an abstract has been...Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference
Data suggest that oral formulations of leuprolide developed utilizing Enteris' Peptelligence® platform successfully deliver meaningful circulating drug concentrations and achieve hormonal suppressive effects which are comparable to parenteral administration BOONTON, N.J., June 13, 2022...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Enteris BioPharma
Sign Up For FreeTo access detailed company insights
MOD3 Pharma specializes in the development of Orally Inhaled and Nasal Drug Products (OINDP), providing clinic-ready solutions through their extensive CMC experience. They offer a range of services including formulation development, cGMP manufacturing, and clinical supply chain management, aimed at efficiently bringing projects to life. Their inten... Read More
